1202163-75-4

Upstream product

• 98-80-6 phenylboronic acid 
• 38496-18-3 2,6-dichloropyridine-3-carboxylic acid 
• 85815-03-8 2-methoxy-6-phenylpyridine-3-carboxylic acid 
• 69750-01-2 2-chloro-6-phenylpyridine-3-carboxylic acid 
• 85815-01-6 methyl 2-methoxy-6-phenyl-pyridine-3-carboxylate 
• 1202163-24-3 methyl 2-carbamoyl-5-dimethylamino-5-phenylpentane-2,4-dienoate 
• 1202163-53-8 (2-methoxy-6-phenylpyridin-3-yl)methanol 
• 125031-47-2 Methyl 1,2-Dihydro-2-oxo-6-phenyl-3-pyridinecarboxylate 

Downstream Products

• 1202164-04-2 tert-butyl 2-(4-(((2-methoxy-6-phenylpyridin-3-yl)methyl)amino)-phenoxy)ethanoate 

Relevant academic research and scientific papers

PYRIDINE DERIVATIVES AND APPLICATION OF ANTI-MACOBACTERIUM THEREOF

The present invention provides a series of pyridine derivatives and their preparation method and application thereof. The series of pyridine derivatives can be applied to treating mycobacterium-related diseases, especially to treatments of fatal mycobacterium-related diseases. The fatal diseases may be related to mycobacterium tuberculosis, mycobacterium bovis, mycobacterium avium, and mycobacterium marinum.

PPAR AGONIST COMPOUNDS, PREPARATION AND USES

The present invention relates to novel PPAR agonist compounds as well as pharmaceutical compositions containing them. The compounds according to the invention are of quite particular therapeutic interest, notably for treating diabetes and/or dyslipidemias, as well as for preventing cardiovascular pathologies.